who should not use glp-1 Safety: Avoid These Medications Who should use GLP-1 medications

The combinational therapy of NaB with GLP-1 has great potential to alleviate NAFL and NASH

This low dose is not intended to trigger immediate weight loss but to help your body adjust to the medication and minimize the likelihood of common gastrointestinal side effects like nausea and vomiting

Some people describe it as a recovery peptide or performance peptide, but these descriptions can oversimplify the science and understate the safety concerns

Cagrilintide, specifically as part of CagriSema, is further along in the regulatory process

Furthermore, GLP-1 decreases glucagon secretion from pancreatic cells and has also extrapancreatic influences as a direct suppressive effect on appetite centers and a slowing of gastric emptying increasing the feeling of satiety